(Q31875056)

4 July 2017

1 reference

title

Phenotypic analysis of mice bearing targeted deletions of 11beta-hydroxysteroid dehydrogenases 1 and 2 genes (English)

1 reference

4 July 2017

Holmes MC

1

1 reference

4 July 2017

Kotelevtsev Y

series ordinal

2

1 reference

4 July 2017

Mullins JJ

series ordinal

3

1 reference

4 July 2017

Seckl JR

series ordinal

4

1 reference

4 July 2017

1 January 2001

1 reference

Molecular and Cellular Endocrinology

4 July 2017

1 reference

4 July 2017

171

1 reference

4 July 2017

1-2

1 reference

4 July 2017

15-20

1 reference

Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Purification of 11 beta-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling technique

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Purification and characterization of the corticosteroid 11 beta-dehydrogenase component of the rat liver 11 beta-hydroxysteroid dehydrogenase complex

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2800%2900386-5

7 January 2021

10.1016/S0303-7207(00)00386-5

Identifiers

DOI

1 reference

4 July 2017

1 reference